185 related articles for article (PubMed ID: 32481365)
1. Cisplatin plus pemetrexed therapy and subsequent immune checkpoint inhibitor administration for malignant peritoneal mesothelioma without pleural lesions: Case report.
Ikushima H; Sakatani T; Ohara S; Takeshima H; Horiuchi H; Morikawa T; Usui K
Medicine (Baltimore); 2020 May; 99(22):e19956. PubMed ID: 32481365
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.
Kitadai R; Shimoi T; Sudo K; Noguchi E; Nagata Y; Sawada R; Takashima A; Boku N; Yonemori K
BMC Cancer; 2021 Mar; 21(1):294. PubMed ID: 33743636
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Malignant Peritoneal Mesothelioma Treated with Cisplatin and Pemetrexed].
Sone T; Omori S; Hayashi K; Yamato H; Ohira K; Kondo N; Takagi Y; Kato K
Gan To Kagaku Ryoho; 2018 Jun; 45(6):993-995. PubMed ID: 30026430
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
Fujimoto N; Aoe K; Kozuki T; Oze I; Kato K; Kishimoto T; Hotta K
Clin Lung Cancer; 2018 Sep; 19(5):e705-e707. PubMed ID: 29853412
[TBL] [Abstract][Full Text] [Related]
5. [A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin].
Kobayashi M; Moriwaki T; Ochi D; Saito R; Kobayashi K; Sugaya A; Akutsu D; Hamano Y; Imanishi M; Yamamoto Y; Yamada T; Nakano N; Sugano M; Hara K; Hyodo I
Gan To Kagaku Ryoho; 2014 Mar; 41(3):361-4. PubMed ID: 24743284
[TBL] [Abstract][Full Text] [Related]
6. First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
Fujimoto E; Kijima T; Kuribayashi K; Negi Y; Kanemura S; Mikami K; Doi H; Kitajima K; Nakano T
Expert Rev Anticancer Ther; 2017 Sep; 17(9):865-872. PubMed ID: 28594258
[TBL] [Abstract][Full Text] [Related]
7. [Malignant Peritoneal Mesothelioma Diagnosed as an Inguinal Mass : A Case Report].
Araki Y; Ikeda M; Iribe Y; Asaoka M; Uemura K; Sano F; Ikeda I
Hinyokika Kiyo; 2021 Oct; 67(10):475-477. PubMed ID: 34742174
[TBL] [Abstract][Full Text] [Related]
8. [Diffuse Malignant Peritoneal Mesothelioma with Secondary Liver Invasion Diagnosed Using Laparoscopy - A Case Report].
Yasuda H; Okumura S; Toyoda S; Yamamoto K; Mizumura N; Itou A; Ogawa M; Kawasaki M; Kameyama M
Gan To Kagaku Ryoho; 2018 Mar; 45(3):449-453. PubMed ID: 29650903
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma.
Nagata Y; Sawada R; Takashima A; Shoji H; Honma Y; Iwasa S; Amano K; Kato K; Hamaguchi T; Shimada Y; Saruta M; Boku N
Jpn J Clin Oncol; 2019 Dec; 49(11):1004-1008. PubMed ID: 31287877
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab for malignant peritoneal mesothelioma.
Tanaka T; Miyamoto Y; Sakai A; Fujimoto N
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257382
[TBL] [Abstract][Full Text] [Related]
11. [A difficult to treat case of malignant peritoneal mesothelioma with peritoneal metastasis].
Ojima T; Takai Y; Yamazaki K; Kamata T; Kanno M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2463-5. PubMed ID: 24394145
[TBL] [Abstract][Full Text] [Related]
12. Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.
Lainakis G; Zagouri F; Kastritis E; Sergentanis TN; Bozas G; Dimopoulos MA; Papadimitriou CA
Tumori; 2011; 97(1):25-9. PubMed ID: 21528659
[TBL] [Abstract][Full Text] [Related]
13. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis.
Marrannes J; Delvaux S; Verheezen J
JBR-BTR; 2009; 92(5):248-50. PubMed ID: 19999328
[TBL] [Abstract][Full Text] [Related]
14. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Taylor L; Ashland J; Ye Z; Monberg MJ; Obasaju CK
Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243
[TBL] [Abstract][Full Text] [Related]
15. Malignant peritoneal mesothelioma (MPM) who responded to rechallenge with cisplatin and pemetrexed with current literature review.
Gilani SN; Gridley R; Searle G; Jegannathen A
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23291819
[TBL] [Abstract][Full Text] [Related]
16. [A case of diffuse peritoneal malignant mesothelioma--intraabdominal administration of cisplatin is useful for diminishing ascites].
Noguchi T; Kawamura M; Kawamura T; Shimamura T; Sasaki K; Hosono T; Sato R; Murakami K
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1975-8. PubMed ID: 20948267
[TBL] [Abstract][Full Text] [Related]
17. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge].
Shukuya T; Takahashi T; Nakamura Y; Yamamoto N
Gan To Kagaku Ryoho; 2010 Mar; 37(3):487-90. PubMed ID: 20332689
[TBL] [Abstract][Full Text] [Related]
18. [A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy].
Igarashi K; Hayashi M; Sato M; Aiba T; Yoneyama O; Waguri N; Furukawa K; Sugimura K; Shibuya H
Nihon Shokakibyo Gakkai Zasshi; 2012 Mar; 109(3):451-9. PubMed ID: 22398911
[TBL] [Abstract][Full Text] [Related]
19. [A case of malignant peritoneal mesothelioma treated effectively with cisplatin and gemcitabine].
Tomie A; Okuyama Y; Enoki Y; Tanaka M; Fukui A; Yoshida N; Fujimoto S
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1971-4. PubMed ID: 20948266
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma.
Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Tanimura H; Tsubota YT
Hepatogastroenterology; 2004; 51(58):1073-83. PubMed ID: 15239250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
